MALAKOFF, France–(BUSINESS WIRE)–Regulatory News: Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment of varicose veins (the “Company”), today announced that the American Medical Association (AMA) CPT Editorial Panel has approved the creation of a new Category III CPT code for non-invasive (HIFU) treatment of varicose veins, performed using Sonovein®. The new code